User grassperson5

Member for: 3 days (since Jul 1)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/snx-2112.html
About: The lungs immuno-oncology prognostic score (LIPS-3): a new prognostic distinction involving patients acquiring first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer.

Activity by grassperson5

Score: 100 points (ranked #2)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for grassperson5

Please log in or register to post on this wall.
...